It has been suggested that VSMC-EGFR contributes to obesity- and T2DM-associated vascular alterations11,15–19, and that hyperglycemia is correlated with an enhanced vascular EGFR activity. This evidence concerns the gene EGFR and obesity due to melanocortin 4 receptor deficiency.